Get started
Author

Mehran Afshar

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
2015 · F.A. Lévi, V. Boige, et al. · Annals of Oncology · 158
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
2023 · Gerhardt Attard, Laura Murphy, et al. · The Lancet Oncology · 134
PDF
Centralisation of radical cystectomies for bladder cancer in England, a decade on from the ‘Improving Outcomes Guidance’: the case for super centralisation
2017 · Mehran Afshar, Henry Goodfellow, et al. · British Journal of Urology · 69
Shifting paradigms in the estimation of survival for castration-resistant prostate cancer: A tertiary academic center experience
2015 · Mehran Afshar, Felicity Evison, et al. · Urologic Oncology Seminars and Original Investigations · 40
Long‐term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis
2020 · Michael Ager, Kelechi Njoku, et al. · British Journal of Urology · 34
PDF
Sarcomatoid Renal Cell Carcinoma: Clinical Outcome and Survival After Treatment With Sunitinib
2014 · Victoria Kunene, Manuela Miscoria, et al. · Clinical Genitourinary Cancer · 33
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project
2016 · Pasquale F Innominato, Sandra Komarzynski, et al. · Journal of Medical Internet Research · 30
Robotic-assisted partial nephrectomy (RAPN) and standardization of outcome reporting: a prospective, observational study on reaching the “Trifecta and Pentafecta”
2020 · D Sri, R. Thakkar, et al. · Journal of Robotic Surgery · 29
PDF
Biliary stenting in advanced malignancy: an analysis of predictive factors for survival
2014 · Mehran Afshar, Yuk Ting Ma, et al. · Cancer Management and Research · 28
PDF
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
2024 · Richard Culliford, Samuel E. D. Lawrence, et al. · Nature Communications · 25
PDF
Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort
2018 · Mehran Afshar, Peter Fletcher, et al. · Oncotarget · 18
PDF
EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma.
2025 · Amit Bahl, Amarnath Challapalli, et al. · Journal of Clinical Oncology · 17
A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib
2017 · CLIVE STUBBS, ANTONIO D BARDOLI, et al. · Anticancer Research · 15
The PD-1/PD-L1 Axis in the Pathogenesis of Urothelial Bladder Cancer and Evaluating its Potential as a Therapeutic Target
2016 · Antonio D Bardoli, Mehran Afshar, et al. · Future Oncology · 13
A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC Trial).
2022 · Emily Renninson, Amarnath Challapalli, et al. · Journal of Clinical Oncology · 12
PDF
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015
2019 · Mehran Afshar, Hiten R.H. Patel, et al. · European Urology Oncology · 12
Predictive factors for response to abiraterone in metastatic castration refractory prostate cancer
2015 · Mehran Afshar, F. Al-Alloosh, et al. · PubMed · 12
PDF
Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center
2014 · Mehran Afshar, Jennifer Pascoe, et al. · Drug Design Development and Therapy · 12
PDF
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials
2026 · Mahaz Kayani, Laura Murphy, et al. · The Lancet Oncology · 11
PDF
Red cell differential width (RDW) as a predictor of survival outcomes with palliative and adjuvant chemotherapy for metastatic penile cancer
2020 · Reena Patel, Louise English, et al. · International Urology and Nephrology · 11
PDF
EPIC-B: Phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma.
2025 · Amarnath Challapalli, Amit Bahl, et al. · Journal of Clinical Oncology · 10
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 9
Nocardia farcinica masquerading as intracerebral metastases in advanced metastatic prostatic cancer
2020 · Claire Livings, Mayu Uemura, et al. · BMJ Case Reports · 8
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?
2019 · Mehran Afshar, Hiten R. H. Patel, et al. · Expert Review of Anticancer Therapy · 7
Methods for Identifying the Cost-effective Case Definition Cut-Off for Sequential Monitoring Tests: An Extension of Phelps and Mushlin
2014 · Roberta Longo, Paul Baxter, et al. · PharmacoEconomics · 6
Works count: 56
Citation count: 783
H-index: 13
I10-index: 21
Year
Topic
Type